Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ache Laboratorios Farmaceuticos SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011800
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that offers generic products. The company provides prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products. Its activities include research, development, production, distribution and commercialization of biotechnology medicines. Ache manufactures cephalosporin antibiotics and commercialization of functional foods. The company exports drugs Canada, Colombia, Peru, Ecuador, Chile, Bolivia, Cista Rica, Venezuela, Mexico, the US and Dominica Republic. It operates through its industrial plants located in Guarulhos, Sao Paulo and Anapolis, Brazil. Ache is headquartered in Guarulhos, Brazil.

Ache Laboratorios Farmaceuticos SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Licensing Agreements 13
Oxford Nutrascience Enters Into Licensing Agreement With Ache Laboratorios 13
Acquisition 14
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 14
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 15
Ache Laboratorios Farmaceuticos SA – Key Competitors 17
Ache Laboratorios Farmaceuticos SA – Key Employees 18
Ache Laboratorios Farmaceuticos SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Key Facts 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ache Laboratorios Farmaceuticos SA, Deals By Therapy Area, 2011 to YTD 2017 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Oxford Nutrascience Enters Into Licensing Agreement With Ache Laboratorios 13
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 14
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 15
Ache Laboratorios Farmaceuticos SA, Key Competitors 17
Ache Laboratorios Farmaceuticos SA, Key Employees 18
Ache Laboratorios Farmaceuticos SA, Subsidiaries 19
Ache Laboratorios Farmaceuticos SA, Joint Venture 19

★海外企業調査レポート[Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ship Finance International Limited (SFL):企業の財務及び戦略的SWOT分析
    Summary Ship Finance International Limited (SFIL), a subsidiary of Frontline is an oil and gas company that owns and operates vessel. The company operates through a fleet of vessels including crude oil tankers for ultra deepwater semi submersible drilling rigs, drybulk carriers, and others. It also …
  • Vanguard Natural Resources, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vanguard Natural Resources, LLC …
  • K2 Energy Limited (KTE):企業概要、財務及び戦略的SWOT分析
    Summary K2 Energy Limited (K2 Energy) is a solar technology development company. The company carries out exploration, development and production of solar technology. It holds investment in Mears Technology Inc. K2 Energy has exposure to the Woodford and Caney shale gas plays that are being developed …
  • Affymax, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Affymax, Inc. Mergers and Acqui …
  • Messer Cutting Systems GmbH:企業の戦略的SWOT分析
    Messer Cutting Systems GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Landry’s, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Landry's, Inc. Mergers and Acqu …
  • System Integrator Corp. (3826):企業の財務及び戦略的SWOT分析
    Summary System Integrator Corp. (SIC) is a software development company that provides information technology services. The company products and services also offer EC site construction, ERP implementation and database development support tool. SIC also offers services inc such as consulting package …
  • Leaf Clean Energy Company (LEAF):企業財務及び戦略的SWOT分析
    Summary Leaf Clean Energy Company (Leaf Clean Energy) is a renewable energy and sustainable technology investment firm. The company offers venture and growth capital across the renewable energy industry to support novelty, well-managed and rapidly-growing companies. It operates and manages clean ene …
  • Hornby Bay Mineral Exploration Ltd.:企業の戦略・SWOT・財務分析
    SummaryHornby Bay Mineral Exploration Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • SacOil Holdings Ltd (SCL):企業のM&A・提携動向(石油・ガス分野)
    Summary SacOil Holdings Ltd (SacOil), formerly known as SA Mineral Resources Corporation Limited, is an upstream oil and gas company that carries out the acquisition, exploration, development and production of hydrocarbon assets in Africa. It concentrates on building a balanced portfolio of Australi …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Hammerson plc:企業の戦略・SWOT・財務分析
    SummaryHammerson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • CSI Compressco LP (CCLP):企業のM&A・提携動向(石油・ガス分野)
    Summary CSI Compressco LP (CSI), formerly Compressco Partners L.P. is a subsidiary of TETRA Technologies, Inc., oilfield consulting company that compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include electrical driven units, …
  • Credit Agricole Egypt (CIEB):企業概要、財務及び戦略的SWOT分析
    Summary Credit Agricole Egypt (Credit Agricole) is a banking service provider. Its personal banking services include current account, certificate deposit, credit card, savings account, time deposit, wedding investment plans, retirement investment plans, investment, prepaid card, MasterCard debit car …
  • Unilever:企業のM&A・提携・投資分析
    Unilever - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Unilever Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Dion Global Solutions Limited (526927):企業概要、財務及び戦略的SWOT分析
    Summary Dion Global Solutions Limited (Dion Global) is a software solutions provider. The company provides cutting-edge solutions and services for the international financial markets. Its product divisions include trading, settlement and wealth management; governance, risk and compliance; messaging …
  • Monica Healthcare Ltd:企業のM&A・提携動向(医療機器分野)
    Summary Monica Healthcare Ltd (MHL) is a medical device company that develops and commercializes labour and delivery monitoring systems for fetal development and uterine activity applications. The company offers products that include monica AN24, monica IF24 and novii wireless patch system is used t …
  • Nantex Industry Co Ltd (2108):企業財務及び戦略的SWOT分析
    Summary Nantex Industry Co Ltd (Nantex) formerly President Fine Chemical Industry Co., Ltd. is a chemical company that manufactures and distributes synthetic rubber products. The company manufactures various grades of MBR, NBR and SBR latexes. Its products include inner shoe soles, synthetic rubber …
  • Douglas Holding AG:戦略・SWOT・企業財務分析
    Douglas Holding AG - Strategy, SWOT and Corporate Finance Report Summary Douglas Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hanmi Pharmaceuticals, Co. Ltd. (128940):企業概要、財務及び戦略的SWOT分析
    Summary Hanmi Pharmaceuticals, Co. Ltd. (Hanmi Pharma) is a pharmaceutical products manufacturer. The company manufactures and supplies prescription drugs and over-the-counter (OTC) drugs. Its prescription drugs include antibiotics, osteoporosis, liver supplements and antiemetics. Hanmi Pharma offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆